Literature DB >> 8092250

Hormonal regulation of MAP kinase in cultured rat inner medullary collecting tubule cells.

L E Heasley1, S I Senkfor, S Winitz, A Strasheim, I Teitelbaum, T Berl.   

Abstract

Mitogen-activated protein (MAP) kinase is a widely expressed protein serine/threonine kinase that serves as a convergence point for many signaling pathways including receptor tyrosine kinases, G protein-coupled receptors, and protein kinase C (PKC). The hormonal regulation of MAP kinase was studied in cultured established rat inner medullary collecting tubule (RIMCT) cells. Neither vasopressin nor beta-adrenergic agonists stimulated MAP kinase, despite clear stimulation of adenosine 3',5'-cyclic monophosphate (cAMP)-dependent protein kinase. In contrast, carbachol, ATP, and epidermal growth factor (EGF), which are known to antagonize vasopressin action in the RIMCT, stimulated the MAP kinase pathway. This stimulation was mimicked by the phorbol ester, 12-O-tetradecanoylphorbol-13-acetate, which directly activates PKC. The potency with which EGF and carbachol activated MAP kinase was similar to the potency with which they inhibited vasopressin-stimulated cAMP accumulation. To assess the role of Gi proteins in these stimulatory events, RIMCT cells were pretreated with pertussis toxin to inhibit Gi-mediated signaling. Pertussis toxin did not influence ATP- or EGF-stimulated MAP kinase, but completely inhibited carbachol stimulation, suggesting that Gi proteins mediate muscarinic stimulation. Prolonged exposure of RIMCT cells to high phorbol ester concentrations to downregulate PKC ablated carbachol- and ATP-stimulated MAP kinase, but not EGF-stimulated MAP kinase, suggesting that PKC is a component of the network involved in MAP kinase activation by purinergic and muscarinic agonists. Investigation of the sidedness of the hormonal stimulations indicated that EGF-stimulated MAP kinase was highly polarized, occurring exclusively from the basolateral surface, whereas carbachol stimulated MAP kinase similarly from either cell surfaces.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8092250     DOI: 10.1152/ajprenal.1994.267.3.F366

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  7 in total

1.  Mitogen-activated protein kinase activation is insufficient for growth factor receptor-mediated PC12 cell differentiation.

Authors:  R R Vaillancourt; L E Heasley; J Zamarripa; B Storey; M Valius; A Kazlauskas; G L Johnson
Journal:  Mol Cell Biol       Date:  1995-07       Impact factor: 4.272

2.  Functional interactions of phosphatidylinositol 3-kinase with GTPase-activating protein in 3T3-L1 adipocytes.

Authors:  D DePaolo; J E Reusch; K Carel; P Bhuripanyo; J W Leitner; B Draznin
Journal:  Mol Cell Biol       Date:  1996-04       Impact factor: 4.272

3.  Expression of GTPase-deficient Ras inhibits vasopressin signaling in cultured cortical collecting duct cells.

Authors:  R Wong; L Heasley; L Ao; T Berl
Journal:  J Clin Invest       Date:  1995-07       Impact factor: 14.808

4.  GTPase-deficient G alpha 16 and G alpha q induce PC12 cell differentiation and persistent activation of cJun NH2-terminal kinases.

Authors:  L E Heasley; B Storey; G R Fanger; L Butterfield; J Zamarripa; D Blumberg; R A Maue
Journal:  Mol Cell Biol       Date:  1996-02       Impact factor: 4.272

5.  Role of extracellular matrix and Ras in regulation of glomerular epithelial cell proliferation.

Authors:  A V Cybulsky; A J McTavish; J Papillon; T Takano
Journal:  Am J Pathol       Date:  1999-03       Impact factor: 4.307

6.  In vivo regulation of MAP kinases in Ratus norvegicus renal papilla by water loading and restriction.

Authors:  P A Wojtaszek; L E Heasley; T Berl
Journal:  J Clin Invest       Date:  1998-11-15       Impact factor: 14.808

7.  c-JUN n-Terminal Kinase (JNK) Signaling in Autosomal Dominant Polycystic Kidney Disease.

Authors:  Abigail O Smith; Julie A Jonassen; Kenley M Preval; Roger J Davis; Gregory J Pazour
Journal:  J Cell Signal       Date:  2022
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.